Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Mesothelioma × Photochemotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Keratosis, Actinic 14 Carcinoma, Non-Small-Cell Lung 7 Squamous Cell Carcinoma of Head and Neck 6 Cholangiocarcinoma 6 Carcinoma, Basal Cell 6 Skin Neoplasms 4 Pancreatic Neoplasms 3 Mesothelioma, Malignant 3 Lung Neoplasms 3 Tongue Neoplasms 2 Pleural Diseases 2 Neoplasms 2 Mycosis Fungoides 2 Leukoplakia, Oral 2 Glioblastoma 2 Esophageal Neoplasms 2 Bile Duct Neoplasms 2 Basal Cell Nevus Syndrome 2 Barrett Esophagus 2 Warts 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Skin Diseases 1 Signs and Symptoms 1 Sezary Syndrome 1 Salivary Gland Neoplasms 1 Retinoblastoma 1 Rectal Neoplasms 1 Precancerous Conditions 1 Pleural Effusion, Malignant 1

Interventions

Pemetrexed 20 Cisplatin 17 Nivolumab 7 Gemcitabine 7 Carboplatin 7 durvalumab 5 Radiotherapy, Intensity-Modulated 4 Ipilimumab 4 Bevacizumab 4 tremelimumab 3 pembrolizumab 3 niraparib 3 Cerebral Decortication 3 Blood Specimen Collection 3 sargramostim 2 Thoracoscopy 2 Surveys and Questionnaires 2 Sorafenib 2 Radiosurgery 2 Oxaliplatin 2 Magnesium Sulfate 2 Leucovorin 2 Imatinib Mesylate 2 Drug Therapy 2 Doxorubicin 2 Dexamethasone 2 Cyclophosphamide 2 sodium thiosulfate 1 pevonedistat 1 perflutren 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02662504 2026-02-05

MesoPDT

University Hospital, Lille

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡